(American Academy of Pediatrics) Although children are more likely than adults to suffer from many diseases, few clinical trials are being conducted to test drugs in pediatric patients, according to a study to be presented Saturday, April 28, at the Pediatric Academic Societies annual meeting in Boston.

Neutra Corp., an emerging nutraceuticals provider, is pleased to announce that clinical trials are now underway on its new and improved weight-loss supplement, Pure Plus Weight Loss.

ARVO is pleased to host a presentation of the one-year results from the U.K.'s Inhibition of VEGF in Age-related Choroidal Neovascularisation (IVAN) study and the two-year results of the Comparison of Age-related Macular Degeneration Treatments Trials (CATT) trial.

(Microbicide Trials Network) Women who use hormonal contraception are at no greater risk of HIV, according to a retrospective review of data from an HIV prevention trial conducted more than three years ago, the latest set of conflicting results on this perplexing issue. Yet tests of stored samples from the ...

Ampio Pharmaceuticals, Inc., a company that discovers and develops new uses for previously approved drugs and new molecular entities ("NMEs"), announced today that it has completed enrollment of patients for its multiple indication diagnostic clinical trials.

The full clinical study reports that drugs that have been authorized for use in patients should be made publicly available in order to allow independent re-analysis of the benefits and risks of such drugs, according to leading international experts who base their assertions on their experience with Tamiflu (oseltamivir). Tamiflu ...

Neutra Corp., an emerging provider of nutraceutical products, announced today that it's gearing up to start a new round of clinical trials on the company's Pure Plus Weight Loss formula, which now includes new ingredients raspberry ketone and African mango.

Stealth Peptides Inc., a privately held biopharmaceutical company developing innovative therapies for diseases with unmet medical needs, announced today the results from three Phase I clinical trials of Bendavia, a novel compound that targets the mitochondrion to treat mitochondrial dysfunction, including ischemia reperfusion and microvascular injury.

A naturally-occurring harmless human virus may be able to boost the effects of two standard chemotherapy drugs in some cancer patients, according to early stage trial data published in Clinical Cancer Research. RT3D, trade name Reolysin, is a new drug developed by Oncolytics Biotech Inc with preclinical and clinical studies ...

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that the two double blind, randomized, placebo controlled, Phase 3 clinical trials for apaziquone did not meet their primary endpoint of a statistically significant difference in the ...

Nanomedicine research at the David H. Koch Institute for Integrative Cancer Research at MIT funded by a $5 million grant from the Prostate Cancer Foundation (PCF) has delivered the first nanomedicine shown to successfully target prostate cancer cells and deliver docetaxel chemotherapy in high concentrations in Phase I clinical trials.

Johnson & Johnson's blood clot preventer Xarelto has come out well in clinical trials, with results comparable to other treatments for blood clotting in the lungs. A study of nearly 5000 patients showed effectiveness and safety were on par with anything else on the market, meaning the drug is poised ...